1474110-21-8 | Gsk2981278

537041-63-7    1474110-21-8 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/160418,2013,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/80369,2015,A1

[3]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

589-16-2    1474110-21-8 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/160418,2013,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/80369,2015,A1

[3]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

[4]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

[5]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

[6]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

1474110-64-9    1474110-21-8 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/160418,2013,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/80369,2015,A1

[3]Chen,Lei;Su,Mei;Jin,Qiu;Wang,Wei;Wang,Chun-Gu;Assani,Israa;Wang,Mu-Xuan;Zhao,Shi-Feng;Lv,Shen-Min;Wang,Jia-Wei;Sun,Bo;Li,Yan;Liao,Zhi-Xin[JournalofMedicinalChemistry,2021,vol.64,#21,p.16106-16131]

1474110-65-0    1474110-21-8 

[1]Chen,Lei;Su,Mei;Jin,Qiu;Wang,Wei;Wang,Chun-Gu;Assani,Israa;Wang,Mu-Xuan;Zhao,Shi-Feng;Lv,Shen-Min;Wang,Jia-Wei;Sun,Bo;Li,Yan;Liao,Zhi-Xin[JournalofMedicinalChemistry,2021,vol.64,#21,p.16106-16131]

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/160418,2013,A1Locationinpatent:Page/Pagecolumn97

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/80369,2015,A1Locationinpatent:Paragraph0396

[4]Barcan,GreggA.;Conde,JoseJ.;Mokhallalati,MohamedK.;Nilson,MarkG.;Xie,Shiping;Allen,C.Liana;Andemichael,YemaneW.;Calandra,NicholasA.;Leitch,DavidC.;Li,Ling;Morris,MichaelJ.[OrganicProcessResearchandDevelopment,2019,vol.23,#7,p.1396-1406]

1474110-21-8    2227219-73-8 

[1]Ouvry,Gilles;Bihl,Franck;Bouix-Peter,Claire;Christin,Olivier;Defoin-Platel,Claire;Deret,Sophie;Feret,Christophe;Froude,David;Hacini-Rachinel,Feriel;Harris,CraigS.;Hervouet,Catherine;Lafitte,Guillaume;Luzy,Anne-Pascale;Musicki,Branislav;Orfila,Danielle;Parnet,Veronique;Pascau,Coralie;Pascau,Jonathan;Pierre,Romain;Raffin,Catherine;Rossio,Patricia;Spiesse,Delphine;Taquet,Nathalie;Thoreau,Etienne;Vatinel,Rodolphe;Vial,Emmanuel;Hennequin,LaurentF.[BioorganicandMedicinalChemistryLetters,2018,vol.28,#8,p.1269-1273]

Title: Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.

Journal: PloS one 20160101

Title: Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20140315

Title: Smith SH, et al. Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin. PLoS One. 2016 Feb 12;11(2):e0147979.